Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER

K-Number: K926334 · 1994-10-18

ApplicantOrthomet, Inc.
Decision Date1994-10-18
Product CodeJWH
Advisory CommitteeOR
DecisionSubstantially Equivalent for Some Indications

Device Summary

AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER is the device name listed in this FDA 510(k) record. The listed applicant is Orthomet, Inc.. It received FDA 510(k) clearance on 1994-10-18 under 510(k) number K926334. The device is classified under product code JWH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent for Some Indications.

Frequently Asked Questions

What is the AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER?

AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER is a medical device that received FDA 510(k) clearance on 1994-10-18. The listed applicant is Orthomet, Inc.. The 510(k) number is K926334.

When did AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER receive FDA 510(k) clearance?

AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER received FDA 510(k) clearance on 1994-10-18, under 510(k) number K926334.

Who is the listed applicant for AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER?

The FDA 510(k) record lists Orthomet, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER?

The FDA product code for AXIOM TOTAL KNEE SYST/ACL RETAIN TIBIAL TRAY/INSER is JWH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Orthomet, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K936310ORTHOMET HMC FEMORAL STEM COMPONENTK945783ORTHOMET TITANIUM HYBRID FEMORAL STEMK943873ORTHOMET ANATOMICALLY GUIDED CARPAL TUNNEL RELEASE SYK944752ORTHOMET RESURFACING FEMORAL COMPONENTK930771PERFECTA TOTAL HIP SYSTEM COATED COCR FEMORAL STEMK931333ORTHOMET ACETABULAR CUP SYSTEM

View all 60 devices →

Related Devices (Code: JWH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262057GMK ExtensionMedacta International SAK260063GSPE SpacerThe General Hospital Corporation, d/b/a MassachusettsK262293EVOLUTION MPX™ Total Knee SystemSuzhou Microport Orthorecon Co., Ltd.K262341b-ONE® Mobio™ Total Knee System Revision Cemented Tibial Augments, Stem Extensions and Press-Fit Stem ExtensionsB-One Ortho, Corp.K262130ATTUNE Revision Knee SystemDepuy Orthopaedics, Inc.K253961SK Knee SystemJust Medical Devices (Tianjin) Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑